NHS must keep medicine rebate down or lose investment
Wednesday 18 February 2026 2:27 pm  |  Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
Patient associations complain over drug price hikes
Cyprus’ patient associations have called for a dialogue on revised categories of drugs, which resulted in higher prices…
All medication users warned to avoid ‘dangerous’ error when taking tablets
A pharmacist has warned all medication users to avoid making a major error when taking tablets. Pharmacist Anum…
FDA will drop two-study requirement for new drug approvals, aiming to speed access :: WRAL.com
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
Telangana High Court Quashes Case For Want Of Complaint U/S 54 NMC Act
The Telangana High Court has held that a Homoeopathy medical practitioner cannot prescribe Allopathy medicines, reiterating the position…
The ‘Mounjaro gap’: How weight-loss drugs are deepening the class divide
When Kelly Todd, 46, entered secondary care for weight management on the NHS four years ago, she quickly…
People dropped out of retatrutide trial for losing too much weight
Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
‘I thought I was going to die as weight-loss jab made me throw up blood’
Emma, 40, was left collapsed on the bathroom floor unable to lift her own headNeil Shaw Assistant Editor…
Novel flu nasal spray may provide short-term protection in pandemic, researchers say
Stephanie Rossow / CDC A vaccine that targets a major cause of diarrheal disease in children in low-income…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
FDA accepts BMS protein degrader for review; Disc rare disease drug rejected
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…